Orphenadrine citrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for orphenadrine citrate and what is the scope of freedom to operate?
Orphenadrine citrate
is the generic ingredient in two branded drugs marketed by Pai Holdings Pharm, Hikma, Rising, Sagent Pharms, Watson Labs, Bausch, Ascot, Bayshore Pharms Llc, Lupin, Sandoz, and Stevens J, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for orphenadrine citrate. Twenty suppliers are listed for this compound.
Summary for orphenadrine citrate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 11 |
NDAs: | 15 |
Drug Master File Entries: | 8 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Patent Applications: | 1,531 |
Drug Prices: | Drug price trends for orphenadrine citrate |
What excipients (inactive ingredients) are in orphenadrine citrate? | orphenadrine citrate excipients list |
DailyMed Link: | orphenadrine citrate at DailyMed |
Pharmacology for orphenadrine citrate
Drug Class | Muscle Relaxant |
Physiological Effect | Centrally-mediated Muscle Relaxation |
US Patents and Regulatory Information for orphenadrine citrate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 040284-001 | Jun 19, 1998 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bayshore Pharms Llc | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 091158-001 | Jul 27, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Watson Labs | ORPHENADRINE CITRATE | orphenadrine citrate | INJECTABLE;INJECTION | 087062-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ascot | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 088067-001 | Apr 6, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | ORPHENADRINE CITRATE | orphenadrine citrate | INJECTABLE;INJECTION | 040463-001 | Mar 4, 2003 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Rising | ORPHENADRINE CITRATE | orphenadrine citrate | INJECTABLE;INJECTION | 040484-001 | May 24, 2006 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.